Project Details
Description
The Site PI (Dr. Khan) and associates will conduct the study as per KUMC Protocol STUDY00146320 [version 1.1a, 5-
28-2021; and any future amendments to that protocol], Randomized IIB Study of the Effect of Bazedoxifene plus
Conjugated Estrogens on Breast Imaging and Tissue Biomarkers in Peri or Post-Menopausal Women at Increased Risk
for Development of Breast Cancer.
Status | Active |
---|---|
Effective start/end date | 2/1/22 → 7/31/26 |
Funding
- University of Kansas Medical Center Research Institute, Inc. (GR16843 AMD 2 // 5R01CA249437-03)
- National Cancer Institute (GR16843 AMD 2 // 5R01CA249437-03)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.